Teva purchase was a right move but wrong timing in combination of generic price dropping so it creates a bigger storm
(you can't control this) but what they can control is their balance sheet and their ability to invest in the area of growth
so they doing that right so credit to them.
Like I said this management what they can control they are doing it and they doing right, what they can't control they will ride it out and that how business should be run.
I am happy with what I see.
Ann: Change of Director's Interest Notice, page-74
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.83 |
Change
-0.200(4.96%) |
Mkt cap ! $325.8M | |||
| Open | High | Low | Value | Volume |
| $4.00 | $4.00 | $3.78 | $852.5K | 220.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1750 | $3.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.85 | 578 | 1 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |